Close Menu

MUNICH--In what is claimed to be the largest amount of seed financing raised by a biotech company in Germany to date, Genome Pharmaceuticals, a functional genomics firm here, has completed a DM6.5 million seed round of venture capital financing led by BB Bioventures, Cambridge, Mass., with Techno Venture Management here as coinvestor. Genome has also applied for state and federal funding from the Bayerische Kapitalbeteiligungsgesellschaft and Technologie Beteiligungs gesellschaft der Deutschen Ausgleichsbank.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.

Sponsored by

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.